美迪凯:拟再融资7亿元 连续两年亏损前次募投项目不达标

Core Viewpoint - Medike (688079.SH) plans to issue A-shares to specific investors, aiming to raise up to 700 million yuan, despite facing significant financial losses in recent years [1] Group 1: Fundraising Plan - The company intends to issue shares to no more than 35 qualified investors, with a maximum of 123 million shares to be issued [1] - The total amount to be raised is capped at 700 million yuan, with 300 million yuan allocated for MEMS device optical system manufacturing, 200 million yuan for semiconductor process bonding prism industrialization, and the remaining 200 million yuan for working capital [1] Group 2: Financial Performance - The company's financial performance has been under pressure, reporting a net profit of 22.09 million yuan in 2022, followed by losses of 84.45 million yuan in 2023, 101.84 million yuan in 2024, and 81.77 million yuan in the first nine months of 2025 [1] - Based on data from the first three quarters of 2025, the company anticipates continued losses for the entire year [1] Group 3: Previous Fundraising Project Performance - The effectiveness of the previous fundraising projects has been disappointing, with the optical optoelectronic component production base project reporting a cumulative loss of 64.85 million yuan as of September 30, 2025, falling short of the promised 283.07 million yuan [1] - The production capacity utilization rate for this project is only 48.56%, primarily due to the project not reaching full capacity [1]